Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Recombinant antibodies are antibody fragments produced by synthetic genes. Recombinant antibodies are used in medical and research applications. Recombinant antibodies in different formats are used in human and pharmaceutical research and production.
The global recombinant antibody production market is divided into five key regions. North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. North America is expected to lead the global recombinant antibody production market. Europe also shows the second largest market in the recombinant antibody production market. The massive R&D expenditures in the development of new drugs in developed regions, coupled with the emergence of large companies in the fields of biotechnology and molecular science, are driving the growth of the recombinant antibody production market in North America and Europe. It is expected that the recombinant antibody production market in the Asia-Pacific region will see significant growth in the next few years.
Increasing research and development in the biopharmaceutical industry is expected to promote the growth of the recombinant antibody production market. Manufacturers are focusing on the production of new antibodies, which is expected to promote the growth of the recombinant antibody production market. The rapid growth of the biopharmaceutical industry is expected to create strong growth opportunities for the recombinant antibody production market. The high demand for recombinant antibodies in the diagnosis and treatment of various diseases is expected to drive the growth of the recombinant antibody production market. Recombinant antibodies have become a treatment for cancer, HIV, and herpes simplex virus. Compared with full-length IgG immunoglobulins, advantages such as better penetration in tumor tissues are expected to benefit the growing recombinant antibody production market.
This report elaborates on the current development of the Recombinant Antibody industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
GE Healthcare
SinoBiological
Medix Biochemica
Bioventix
Abnova
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Single Chain Variable Fragment (scFv)
Fab Fragment
Bispecific Recombinant Antibodies (Diabodies)
Application:
Hospital
Scientific Research
Others
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Recombinant Antibody Industry Overview
-
1.1.1 Recombinant Antibody Market Scope and Market Segments
-
1.1.2 Recombinant Antibody Industry Characteristics
-
1.1.3 Global and China Recombinant Antibody Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Recombinant Antibody Production Value and Growth Rate (2017-2028)
-
1.2 Global Recombinant Antibody Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Single Chain Variable Fragment (scFv)
-
1.2.2 Fab Fragment
-
1.2.3 Bispecific Recombinant Antibodies (Diabodies)
-
1.3 Global Recombinant Antibody Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Hospital
-
1.3.2 Scientific Research
-
1.3.3 Others
-
1.4 Market Analysis by Region
-
1.4.1 North America Recombinant Antibody Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Recombinant Antibody Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Recombinant Antibody Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Recombinant Antibody Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Recombinant Antibody Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Recombinant Antibody Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Recombinant Antibody Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Recombinant Antibody Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Recombinant Antibody Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Recombinant Antibody Industry Porter's Five Forces Model Analysis
-
2.2.3 Recombinant Antibody Industry PEST Analysis
-
2.3 Recombinant Antibody Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Recombinant Antibody Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Recombinant Antibody Industry
Chapter 3 Global and China Recombinant Antibody Market, by Manufacturer
-
3.1 Global and China Recombinant Antibody Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Recombinant Antibody Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Recombinant Antibody Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Recombinant Antibody Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Recombinant Antibody Market Top 3 Players
Chapter 4 Global and China Recombinant Antibody Market, by Type (2017-2028)
-
4.1 Recombinant Antibody Market Trend, by Type
-
4.2 Global Recombinant Antibody Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Recombinant Antibody Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Recombinant Antibody Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Recombinant Antibody Price Trend, by Type (2017-2028)
-
4.3 China Recombinant Antibody Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Recombinant Antibody Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Recombinant Antibody Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Recombinant Antibody Price Trend, by Type (2017-2028)
Chapter 5 Global and China Recombinant Antibody Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Recombinant Antibody Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Recombinant Antibody Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Recombinant Antibody Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Recombinant Antibody Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Recombinant Antibody Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Recombinant Antibody Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Recombinant Antibody Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Recombinant Antibody Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Recombinant Antibody Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Recombinant Antibody Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Recombinant Antibody Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Recombinant Antibody Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Recombinant Antibody Market Analysis
-
7.1 North America Recombinant Antibody Market, by Type
-
7.2 North America Recombinant Antibody Market, by Application
-
7.3 North America Recombinant Antibody Market Analysis and Forecast, by Country
-
7.3.1 United States Recombinant Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Recombinant Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Recombinant Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Recombinant Antibody Market Analysis
-
8.1 Europe Recombinant Antibody Market, by Type
-
8.2 Europe Recombinant Antibody Market, by Application
-
8.3 Europe Recombinant Antibody Market Analysis and Forecast, by Country
-
8.3.1 Germany Recombinant Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Recombinant Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Recombinant Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Recombinant Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Recombinant Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Recombinant Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Recombinant Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Recombinant Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Recombinant Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Recombinant Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Recombinant Antibody Market Analysis
-
9.1 APAC Recombinant Antibody Market, by Type
-
9.2 APAC Recombinant Antibody Market, by Application
-
9.3 APAC Recombinant Antibody Market Analysis and Forecast, by Country
-
9.3.1 China Recombinant Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Recombinant Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Recombinant Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Recombinant Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Recombinant Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Recombinant Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Recombinant Antibody Market Analysis
-
10.1 Latin America, Middle East and Africa Recombinant Antibody Market, by Type
-
10.2 Latin America, Middle East and Africa Recombinant Antibody Market, by Application
-
10.3 Latin America, Middle East and Africa Recombinant Antibody Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Recombinant Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Recombinant Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Recombinant Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Recombinant Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Recombinant Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Recombinant Antibody Company Profiles
-
11.1 GE Healthcare
-
11.1.1 GE Healthcare Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 GE Healthcare Recombinant Antibody Product Profiles, Application and Specification
-
11.1.3 GE Healthcare Recombinant Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 SinoBiological
-
11.2.1 SinoBiological Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 SinoBiological Recombinant Antibody Product Profiles, Application and Specification
-
11.2.3 SinoBiological Recombinant Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Medix Biochemica
-
11.3.1 Medix Biochemica Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Medix Biochemica Recombinant Antibody Product Profiles, Application and Specification
-
11.3.3 Medix Biochemica Recombinant Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Bioventix
-
11.4.1 Bioventix Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Bioventix Recombinant Antibody Product Profiles, Application and Specification
-
11.4.3 Bioventix Recombinant Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Abnova
-
11.5.1 Abnova Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Abnova Recombinant Antibody Product Profiles, Application and Specification
-
11.5.3 Abnova Recombinant Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Recombinant Antibody Industry Investment Prospect and Risk Assessment
-
12.1 Recombinant Antibody Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Recombinant Antibody Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Recombinant Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure China Recombinant Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure Global Recombinant Antibody Production Value and Growth Rate (2017-2028)
-
Figure China Recombinant Antibody Production Value and Growth Rate (2017-2028)
-
Figure Global Recombinant Antibody Market Size and Growth Rate of Single Chain Variable Fragment (scFv) (2017-2028)
-
Figure Global Recombinant Antibody Market Size and Growth Rate of Fab Fragment (2017-2028)
-
Figure Global Recombinant Antibody Market Size and Growth Rate of Bispecific Recombinant Antibodies (Diabodies) (2017-2028)
-
Figure Global Recombinant Antibody Market Size and Growth Rate of Hospital (2017-2028)
-
Figure Global Recombinant Antibody Market Size and Growth Rate of Scientific Research (2017-2028)
-
Figure Global Recombinant Antibody Market Size and Growth Rate of Others (2017-2028)
-
Figure North America Recombinant Antibody Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Recombinant Antibody Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Recombinant Antibody Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Recombinant Antibody Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Recombinant Antibody Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Recombinant Antibody Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Recombinant Antibody Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Recombinant Antibody Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Recombinant Antibody Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Recombinant Antibody Market Share, by Manufacturer in 2021
-
Figure Global and China Recombinant Antibody Market Share, by Manufacturer in 2022
-
Table Global Recombinant Antibody Sales Volume, by Type (2017-2028)
-
Table Global Recombinant Antibody Sales Volume Share, by Type (2017-2028)
-
Figure Global Recombinant Antibody Sales Volume Share, by Type (2017-2028)
-
Table Global Recombinant Antibody Sales Value, by Type (2017-2028)
-
Table Global Recombinant Antibody Sales Value Share, by Type (2017-2028)
-
Figure Global Recombinant Antibody Price Trend, by Type (2017-2028)
-
Table China Recombinant Antibody Sales Volume, by Type (2017-2028)
-
Table China Recombinant Antibody Sales Volume Share, by Type (2017-2028)
-
Figure China Recombinant Antibody Sales Volume Share, by Type (2017-2028)
-
Table China Recombinant Antibody Sales Value, by Type (2017-2028)
-
Table China Recombinant Antibody Sales Value Share, by Type (2017-2028)
-
Figure China Recombinant Antibody Price Trend, by Type (2017-2028)
-
Table Global Recombinant Antibody Sales Volume, by Application (2017-2028)
-
Table Global Recombinant Antibody Sales Volume Share, by Application (2017-2028)
-
Figure Global Recombinant Antibody Sales Volume Share, by Application (2017-2028)
-
Table Global Recombinant Antibody Sales Value, by Application (2017-2028)
-
Table Global Recombinant Antibody Sales Value Share, by Application (2017-2028)
-
Figure Global Recombinant Antibody Sales Value Share, by Application (2017-2028)
-
Table China Recombinant Antibody Sales Volume, by Application (2017-2028)
-
Table China Recombinant Antibody Sales Volume Share, by Application (2017-2028)
-
Figure China Recombinant Antibody Sales Volume Share, by Application (2017-2028)
-
Table China Recombinant Antibody Sales Value, by Application (2017-2028)
-
Table China Recombinant Antibody Sales Value Share, by Application (2017-2028)
-
Figure China Recombinant Antibody Sales Value Share, by Application (2017-2028)
-
Figure China Recombinant Antibody Production, Import, Consumption and Export (2017-2022)
-
Figure North America Recombinant Antibody Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Recombinant Antibody Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Recombinant Antibody Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Recombinant Antibody Production, Import, Consumption and Export (2017-2022)
-
Table North America Recombinant Antibody Sales Volume, by Type (2017-2028)
-
Table North America Recombinant Antibody Sales Volume Share, by Type (2017-2028)
-
Figure North America Recombinant Antibody Sales Volume Share, by Type (2017-2028)
-
Table North America Recombinant Antibody Sales Volume, by Application (2017-2028)
-
Table North America Recombinant Antibody Sales Volume Share, by Application (2017-2028)
-
Figure North America Recombinant Antibody Sales Volume Share, by Application (2017-2028)
-
Figure United States Recombinant Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure United States Recombinant Antibody Sales Value and Growth Rate (2017-2028)
-
Figure Canada Recombinant Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Recombinant Antibody Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Recombinant Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Recombinant Antibody Sales Value and Growth Rate (2017-2028)
-
Table Europe Recombinant Antibody Sales Volume, by Type (2017-2028)
-
Table Europe Recombinant Antibody Sales Volume Share, by Type (2017-2028)
-
Figure Europe Recombinant Antibody Sales Volume Share, by Type (2017-2028)
-
Table Europe Recombinant Antibody Sales Volume, by Application (2017-2028)
-
Table Europe Recombinant Antibody Sales Volume Share, by Application (2017-2028)
-
Figure Europe Recombinant Antibody Sales Volume Share, by Application (2017-2028)
-
Figure Germany Recombinant Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Recombinant Antibody Sales Value and Growth Rate (2017-2028)
-
Figure UK Recombinant Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure UK Recombinant Antibody Sales Value and Growth Rate (2017-2028)
-
Figure France Recombinant Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure France Recombinant Antibody Sales Value and Growth Rate (2017-2028)
-
Figure Italy Recombinant Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Recombinant Antibody Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Recombinant Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Recombinant Antibody Sales Value and Growth Rate (2017-2028)
-
Figure Spain Recombinant Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Recombinant Antibody Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Recombinant Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Recombinant Antibody Sales Value and Growth Rate (2017-2028)
-
Figure Poland Recombinant Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Recombinant Antibody Sales Value and Growth Rate (2017-2028)
-
Figure Russia Recombinant Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Recombinant Antibody Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Recombinant Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Recombinant Antibody Sales Value and Growth Rate (2017-2028)
-
Table APAC Recombinant Antibody Sales Volume, by Type (2017-2028)
-
Table APAC Recombinant Antibody Sales Volume Share, by Type (2017-2028)
-
Figure APAC Recombinant Antibody Sales Volume Share, by Type (2017-2028)
-
Table APAC Recombinant Antibody Sales Volume, by Application (2017-2028)
-
Table APAC Recombinant Antibody Sales Volume Share, by Application (2017-2028)
-
Figure APAC Recombinant Antibody Sales Volume Share, by Application (2017-2028)
-
Figure China Recombinant Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure China Recombinant Antibody Sales Value and Growth Rate (2017-2028)
-
Figure Japan Recombinant Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Recombinant Antibody Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Recombinant Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Recombinant Antibody Sales Value and Growth Rate (2017-2028)
-
Figure India Recombinant Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure India Recombinant Antibody Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Recombinant Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Recombinant Antibody Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Recombinant Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Recombinant Antibody Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Recombinant Antibody Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Recombinant Antibody Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Recombinant Antibody Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Recombinant Antibody Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Recombinant Antibody Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Recombinant Antibody Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Recombinant Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Recombinant Antibody Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Recombinant Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Recombinant Antibody Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Recombinant Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Recombinant Antibody Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Recombinant Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Recombinant Antibody Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Recombinant Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Recombinant Antibody Sales Value and Growth Rate (2017-2028)
-
Table GE Healthcare Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table GE Healthcare Product Profiles, Application and Specification
-
Table GE Healthcare Recombinant Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table SinoBiological Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table SinoBiological Product Profiles, Application and Specification
-
Table SinoBiological Recombinant Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Medix Biochemica Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Medix Biochemica Product Profiles, Application and Specification
-
Table Medix Biochemica Recombinant Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Bioventix Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Bioventix Product Profiles, Application and Specification
-
Table Bioventix Recombinant Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Abnova Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Abnova Product Profiles, Application and Specification
-
Table Abnova Recombinant Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
